1. Home
  2. IXHL vs BLAC Comparison

IXHL vs BLAC Comparison

Compare IXHL & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IXHL
  • BLAC
  • Stock Information
  • Founded
  • IXHL 2001
  • BLAC 2020
  • Country
  • IXHL Australia
  • BLAC United States
  • Employees
  • IXHL N/A
  • BLAC N/A
  • Industry
  • IXHL
  • BLAC
  • Sector
  • IXHL
  • BLAC
  • Exchange
  • IXHL Nasdaq
  • BLAC NYSE
  • Market Cap
  • IXHL 39.2M
  • BLAC 46.9M
  • IPO Year
  • IXHL N/A
  • BLAC 2023
  • Fundamental
  • Price
  • IXHL $1.93
  • BLAC $11.35
  • Analyst Decision
  • IXHL
  • BLAC
  • Analyst Count
  • IXHL 0
  • BLAC 0
  • Target Price
  • IXHL N/A
  • BLAC N/A
  • AVG Volume (30 Days)
  • IXHL 24.2K
  • BLAC 510.0
  • Earning Date
  • IXHL 11-14-2024
  • BLAC 01-01-0001
  • Dividend Yield
  • IXHL N/A
  • BLAC N/A
  • EPS Growth
  • IXHL N/A
  • BLAC N/A
  • EPS
  • IXHL N/A
  • BLAC N/A
  • Revenue
  • IXHL $86,000.00
  • BLAC N/A
  • Revenue This Year
  • IXHL $3,817.06
  • BLAC N/A
  • Revenue Next Year
  • IXHL $66.67
  • BLAC N/A
  • P/E Ratio
  • IXHL N/A
  • BLAC N/A
  • Revenue Growth
  • IXHL N/A
  • BLAC N/A
  • 52 Week Low
  • IXHL $1.50
  • BLAC $11.40
  • 52 Week High
  • IXHL $8.47
  • BLAC $13.40
  • Technical
  • Relative Strength Index (RSI)
  • IXHL 52.16
  • BLAC 50.58
  • Support Level
  • IXHL $1.71
  • BLAC $11.32
  • Resistance Level
  • IXHL $2.19
  • BLAC $11.60
  • Average True Range (ATR)
  • IXHL 0.16
  • BLAC 0.04
  • MACD
  • IXHL -0.00
  • BLAC -0.01
  • Stochastic Oscillator
  • IXHL 41.12
  • BLAC 21.88

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About BLAC BELLEVUE LIFE SCIENCES ACQ CORP

Bellevue Life Sciences Acquisition Corp is a blank check company.

Share on Social Networks: